Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/2101
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSetia, Ankuri-
dc.date.accessioned2024-05-02T09:26:05Z-
dc.date.available2024-05-02T09:26:05Z-
dc.date.issued2014-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/2101-
dc.language.isoen_USen_US
dc.publisherIIHMR Universityen_US
dc.subjectHospitalen_US
dc.subjectMarket Opportunityen_US
dc.subjectBiosimilar Regulatory Approvaen_US
dc.subjectRegulatory Environmenten_US
dc.subjectPharmerging Marketen_US
dc.titleMarket Opportunity Analysis for Biosimilars from Perspective of Regulatory Environment Offered in EU5, U.S., Japan and Pharmerging Marketsen_US
dc.typeDissertationen_US
dc.guideKhanna, Anoopen_US
dc.organizationnameZS Associates India Private Limited, New Delhien_US
Appears in Collections:2014

Files in This Item:
File Description SizeFormat 
Ankuri Setia-Dis.pdfDissertation Report1.65 MBAdobe PDF Preview PDFDownload
Ankuri Setia-Int.pdfInternship101.28 kBAdobe PDF Preview PDFDownload
Ankuri Setia-PPT.pdfPresentation620.29 kBAdobe PDF Preview PDFDownload


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.